Related Experiment Video
Updated: Jun 23, 2026
11:52
Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
Published on: August 4, 2016
Gene-expression profiling of adrenocortical carcinoma
Insoo Suh1, Marlon A Guerrero, Electron Kebebew
1Department of Surgery, University of California, San Francisco, CA 94143, USA
Expert Review of Molecular Diagnostics
|May 16, 2009
Summary
Adrenocortical carcinoma (ACC) is a rare cancer with poor outcomes. Gene-expression profiling offers new hope for identifying diagnostic markers and improving treatment for this aggressive malignancy.
Area of Science:
- Oncology
- Molecular Biology
Background:
- Adrenocortical carcinoma (ACC) is a rare adrenal cortex cancer with a poor prognosis.
- Current diagnostic methods struggle to differentiate benign from malignant adrenocortical tumors.
- Limited understanding of molecular carcinogenesis hinders ACC treatment advancements.
Purpose of the Study:
- To review the limitations in managing ACC.
- To explore gene-expression profile studies for diagnostic and prognostic markers.
- To highlight the need for novel therapeutic strategies in ACC.
Main Methods:
- Review of existing literature on adrenocortical carcinoma.
- Analysis of gene-expression profile studies published since 2003.
- Discussion of diagnostic and prognostic implications of gene expression in ACC.
Main Results:
- Gene-expression profiling shows promise in distinguishing benign from malignant adrenocortical tumors.
- Distinct gene-expression profiles may serve as diagnostic and prognostic clinical utility markers.
- Significant improvements in ACC treatment are lacking, necessitating new approaches.
Conclusions:
- Gene-expression analysis is a valuable tool for understanding ACC.
- Identifying molecular markers can improve ACC diagnosis and prognosis.
- Further research into gene profiles is crucial for developing effective ACC therapies.
